Toronto, Ontario–(Newsfile Corp. – July 9, 2020) – Therma Bright Inc. (TSXV: THRM), (“Therma Bright” or the “Company”), a progressive medical device technology company, is pleased to announce that it has completed due diligence and will move forward with closing of the asset purchase transaction with Saringer Life Science Technologies Inc. (“Saringer”). As previously reported on January 15, 2020 and April 8th, 2020, the Company entered a non-binding letter of intent (“LOI”) to acquire Benepod®pain relief technology and other medical device related technology from Saringer. The terms as outlined in the press release issued on January 15, 2020 will remain the same in the definitive agreement.
More information about Saringer products can be found at:
The transaction will be subject to TSX Venture Exchange approval.
Rob Fia, CEO, commented:
“We are excited to move forward to close the transaction with Saringer and to add innovative, drug fee pain relief technology to our stable of products. Saringer’s BenePod®technology is a proven pain relief technology that continues to have long life intellectual property. We expect to market BenePod® technology and Saringer’s other products worldwide after the transaction closes.”